GetTopicDetailResponse(id=fe8d18812fb, topicName=XELOX, introduction=XELOX, content=null, image=null, comments=0, allHits=1195, url=https://h5.medsci.cn/topic?id=18812, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=6354, tagList=[TagDto(tagId=6354, tagName=XELOX)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2244608, encodeId=42f22244608ff, content=<a href='/topic/show?id=0a9e922085f' target=_blank style='color:#2F92EE;'>#貝伐珠單抗#</a> <a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#轉(zhuǎn)移性結(jié)直腸癌#</a> <a href='/topic/show?id=fe8d18812fb' target=_blank style='color:#2F92EE;'>#XELOX#</a> <a href='/topic/show?id=439e11583569' target=_blank style='color:#2F92EE;'>#SHR-1701#</a>, objectTitle=STTT | SHR-1701聯(lián)合XELOX和貝伐珠單抗一線治療不可切除轉(zhuǎn)移性結(jié)直腸癌的療效和安全性, objectType=article, longId=856087, objectId=24f485608ef5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241219/1734613463104_6145188.png, objectUrl=/article/show_article.do?id=24f485608ef5, replyNumber=0, likeNumber=55, createdTime=2024-12-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亞, moduleDTOList=[ModuleDTO(moduleId=24f485608ef5, moduleTitle=STTT | SHR-1701聯(lián)合XELOX和貝伐珠單抗一線治療不可切除轉(zhuǎn)移性結(jié)直腸癌的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=24f485608ef5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197702, encodeId=3c51219e70204, content=<a href='/topic/show?id=0a9e922085f' target=_blank style='color:#2F92EE;'>#貝伐珠單抗#</a> <a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#轉(zhuǎn)移性結(jié)直腸癌#</a> <a href='/topic/show?id=fe8d18812fb' target=_blank style='color:#2F92EE;'>#XELOX#</a>, objectTitle=STTT | XELOX聯(lián)合貝伐珠單抗治療未經(jīng)治療的轉(zhuǎn)移性結(jié)直腸癌：一項(xiàng)隨機(jī)對(duì)照Ⅲ期臨床試驗(yàn), objectType=article, longId=820931, objectId=f24c82093171, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240409/1712678339361_6145188.jpg, objectUrl=/article/show_article.do?id=f24c82093171, replyNumber=0, likeNumber=105, createdTime=2024-04-10, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f24c82093171, moduleTitle=STTT | XELOX聯(lián)合貝伐珠單抗治療未經(jīng)治療的轉(zhuǎn)移性結(jié)直腸癌：一項(xiàng)隨機(jī)對(duì)照Ⅲ期臨床試驗(yàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f24c82093171)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
